Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHemogenyx Regulatory News (HEMO)

Share Price Information for Hemogenyx (HEMO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.50
Bid: 1.48
Ask: 1.546
Change: 0.00 (0.00%)
Spread: 0.066 (4.459%)
Open: 1.50
High: 0.00
Low: 0.00
Prev. Close: 1.50
HEMO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Broker

16 Nov 2015 07:00

RNS Number : 7859F
Silver Falcon PLC
16 November 2015
 

16 November 2015

 

Silver Falcon PLC

(the "Company")

 

Appointment of Broker

 

Silver Falcon PLC (LSE: SILF), the Main Board listed investment vehicle set up to acquire businesses in the FinTech space, is pleased to announce that it has appointed Optiva Securities Limited as sole Broker with immediate effect.

 

Geoffrey Dart, Chairman, commented:

 

"We are delighted that Optiva Securities has agreed to work with Silver Falcon as its Broker. As we continue to follow our acquisition led strategy in the Financial Services sector, and in particular the FinTech sub-sector, we look forward to benefiting from Optiva's substantial experience representing and advising companies on a global scale."

 

Ends

 

 

For more information contact:

 

Silver Falcon PLC Tel: +44 (0) 20 3757 4980

Geoffrey Dart C/O Camarco

 

Camarco Tel: +44 (0) 20 3757 4980

Jennifer Renwick / Billy Clegg / Zoё Moulton

 

Optiva Securities Limited Tel: +44 (0) 20 3137 1904

Christian Dennis / Jeremy King

 

Notes to Editors:

 

 

About Optiva Securities Limited

 

Optiva Securities Limited is a privately owned company, a full member of the London Stock Exchange and an AIM broker. It was formed in 2008 through a management buy in of Sectram Limited, an Institutional dealing business. Optiva has its global headquarters in London and international representation in Geneva, Switzerland.

 

For more information on Optiva Securities Limited, please visit: http://www.optivasecurities.com/.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
APPGGGQAGUPAUQQ
Date   Source Headline
1st May 20202:06 pmRNSSecond Price Monitoring Extn
1st May 20202:00 pmRNSPrice Monitoring Extension
30th Apr 20204:57 pmRNSFinal Results
30th Apr 20204:40 pmRNSSecond Price Monitoring Extn
30th Apr 20204:36 pmRNSPrice Monitoring Extension
30th Apr 20202:05 pmRNSSecond Price Monitoring Extn
30th Apr 20202:00 pmRNSPrice Monitoring Extension
30th Apr 202011:05 amRNSSecond Price Monitoring Extn
30th Apr 202011:00 amRNSPrice Monitoring Extension
29th Apr 20204:42 pmRNSSecond Price Monitoring Extn
29th Apr 20204:36 pmRNSPrice Monitoring Extension
29th Apr 202011:05 amRNSSecond Price Monitoring Extn
29th Apr 202011:00 amRNSPrice Monitoring Extension
29th Apr 20209:06 amRNSSecond Price Monitoring Extn
29th Apr 20209:00 amRNSPrice Monitoring Extension
28th Apr 20202:06 pmRNSSecond Price Monitoring Extn
28th Apr 20202:00 pmRNSPrice Monitoring Extension
28th Apr 202011:06 amRNSSecond Price Monitoring Extn
28th Apr 202011:00 amRNSPrice Monitoring Extension
27th Apr 20204:41 pmRNSSecond Price Monitoring Extn
27th Apr 20204:36 pmRNSPrice Monitoring Extension
27th Apr 20202:06 pmRNSSecond Price Monitoring Extn
27th Apr 20202:00 pmRNSPrice Monitoring Extension
22nd Apr 20204:40 pmRNSSecond Price Monitoring Extn
22nd Apr 20204:35 pmRNSPrice Monitoring Extension
22nd Apr 20202:05 pmRNSSecond Price Monitoring Extn
22nd Apr 20202:00 pmRNSPrice Monitoring Extension
22nd Apr 202011:00 amRNSCOVID-19 Project Initiated
21st Apr 20202:26 pmRNSApproval and Issuance of European Hu-PHEC Patent
2nd Apr 20202:05 pmRNSSecond Price Monitoring Extn
2nd Apr 20202:00 pmRNSPrice Monitoring Extension
28th Feb 20206:30 pmRNSTotal Voting Rights
20th Feb 20207:00 amRNSHEMO-CAR-T cells Effective Against AML in vivo
20th Feb 20207:00 amRNSHEMO-CAR-T cells Effective Against AML in vivo
11th Feb 20207:00 amRNSApproval and Issuance of U.S. Hu-PHEC Patent
31st Jan 20207:00 amRNSDirector/PDMR Shareholding
30th Jan 20202:05 pmRNSPlacing and Subscription to raise £650,000
15th Jan 202012:30 pmRNSHEMO's CAR-T Cells Effective Against AML in vitro
18th Nov 20197:00 amRNSOperational Update
12th Nov 20197:00 amRNSPresentation at the Investival Showcase
6th Nov 20197:00 amRNSPresentation at the NY Oncology Investor Conf.
23rd Oct 20197:00 amRNSResearch Agreement with Global Pharma Company
21st Oct 20197:00 amRNSPresentation at NY Stem Cell Foundation conference
30th Sep 20197:00 amRNSHalf-year Report
12th Sep 20197:00 amRNSHemogenyx scientific advisor receives Lasker Award
1st Aug 20197:00 amRNSTotal Voting Rights
12th Jul 20197:00 amRNSCDX Patent Application
3rd Jul 20197:00 amRNSDirector/PDMR Shareholding
28th Jun 201912:19 pmRNSResult of AGM
24th Jun 20197:00 amRNSDevelopment of ApbHC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.